Central Pharma suffers losses in Jul-Sep quarter
Central Pharmaceuticals Limited posted losses in the first quarter of the current financial year of 2022-23.
The drug-maker incurred a loss of Tk 95.84 lakh in the July-September quarter, equaling the loss it suffered in the same quarter a year earlier.
Its earnings per share were Tk 0.08 in negative in July-September this year against Tk 0.08 in negative during the same quarter a year earlier, showed the unaudited financial statements.
The net operating cash flow per share was nil in the first quarter this fiscal year as well as in the same three-month quarter of the last financial year.
The net asset value per share was Tk 5.88 on September 30 and Tk 5.96 on June 30.
Shares of Central Pharmaceuticals were unchanged at Tk 12.40 on the Dhaka Stock Exchange yesterday.